ResMed's Sales and Profits Rise
ResMed (NYSE: RMD), a medical device marker focused on continuous positive airway pressure (CPAP) machines and accessories, reported its fiscal first-quarter results on Thursday, Oct. 26. The company's top and bottom lines once again moved in the right direction and compared favorably to what market watchers had predicted. Investors applauded the company's success.
Image source: Getty Images.
Metric
Source: Fool.com
Resmed Inc. Stock
€202.40
0.400%
Resmed Inc. is currently one of the favorites of our community with 19 Buy predictions and no Sell predictions.
As a result the target price of 207 € shows a slightly positive potential of 2.27% compared to the current price of 202.4 € for Resmed Inc..
